ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

VLG Venture Life Group Plc

38.25
0.05 (0.13%)
Last Updated: 08:00:08
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Venture Life Group Plc LSE:VLG London Ordinary Share GB00BFPM8908 ORD 0.3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 0.13% 38.25 38.00 38.50 38.25 38.25 38.25 27,379 08:00:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Misc Retail Stores, Nec 51.41M 921k 0.0072 53.06 48.53M
Venture Life Group Plc is listed in the Misc Retail Stores sector of the London Stock Exchange with ticker VLG. The last closing price for Venture Life was 38.20p. Over the last year, Venture Life shares have traded in a share price range of 32.00p to 49.50p.

Venture Life currently has 127,052,312 shares in issue. The market capitalisation of Venture Life is £48.53 million. Venture Life has a price to earnings ratio (PE ratio) of 53.06.

Venture Life Share Discussion Threads

Showing 36776 to 36799 of 36850 messages
Chat Pages: 1474  1473  1472  1471  1470  1469  1468  1467  1466  1465  1464  1463  Older
DateSubjectAuthorDiscuss
07/8/2024
13:06
I reckon Slater is picking up stock.. Net debt reduction was very impressive.
celeritas
06/8/2024
11:24
Overall a good trading update but disappointing to see revenue flat at £23.5m. VLG brands put in a storming performance +27% in H1 23, so this was always going to be a headwind.

Broker forecast is FY revenue £55m so based on 45/55% split, H1 ideally should have come in around £24.75 which is a tad behind expectations.
Revenue of £31.5m is required in H2, but management states it has good visibility with further new listings and new international business (esp Jaguar Health) coming on stream.

Net debt reduced by £3m to £10.7m despite investment into medical device Regs and new product development. Cavendish estimates FY net debt at £9.2m by FY end, but today suggests this could come in £770K lower at £8.5m.

M&A should be on the cards again soon as the CEO says 'Some really good opportunities are out there'.

Lots to like here at a valuation that fails to reflect the bright growth prospects IMHO.

eagle eye
06/8/2024
07:16
Promise of future growth. Customer brands down 6% with inflation the other way not good. VLG up 6% but will need to be up 17% 2nd half to meet 55m expectations.. Good to see margin continue to improve and positive net debt story continues..I would expect a modest drop in share price until hinted at strategic investment comes through, maybe before interims.
chester9
06/8/2024
06:56
Cash and debt

Solid free cashflow generation in the Period resulted in a further net debt reduction of approximately £3.0m to £10.7m (31 December 2023: £13.7m). Group leverage is anticipated to fall below 0.8x by the end of the year (31 December 2023: 1.3x) and presents more opportunity to explore strategic investment through attractive and accretive M&A.

celeritas
06/8/2024
06:34
Positive & in line H1'24 trading update today from consumer healthcare products firm. All the news & commentary here.

Brief note:

CEO Interview -

brummy_git
06/8/2024
06:05
Surprised the numbers weren't higher given the confidence of the statement A pullback today but further rises over the coming months to accommodate the increased second half numbers and performance
basem1
31/7/2024
13:19
Yes thanks ee
thedudie
31/7/2024
13:08
My pleasure. It's far more efficient than everyone contacting VLG individually :-))
eagle eye
31/7/2024
12:42
Thanks for following up on the TU date, Eagle - much appreciated, Lammy.
lammylover
31/7/2024
11:49
VLG have replied and the TU will now be beginning of August.
I've asked be notified the day before, so will post again if I hear anything.

eagle eye
31/7/2024
08:13
I've contacted VLG this morning to find out what's happening with the TU.
I'll post here when I receive a reply.

eagle eye
31/7/2024
07:15
Something else happening to delay it? Sorry I know that's obvious!!
bagpuss67
30/7/2024
08:33
update tomorrow apparently
wooster4
29/7/2024
14:08
They have got the debt down quicker than I thought likely so I would want them in the next few months to start leveraging the debt facility they have by buying some new brands.
If they don't and the debt has been reduced into single figure millions by end of year then they will be on borrowed time.

thedudie
29/7/2024
12:15
I do think vlg are on borrowed time. They have built up a number of brands now, collected them together for a larger suiter who will take vlg's products and push them into many more markets much quicker than vlg. APH for one, vlg already manufacture a number of products for them never even mind bigger outfits.
The scope is vast and I'm sure bigger co's will see that.

celeritas
29/7/2024
11:57
VLG were appointed as second manufacturer of Alliance Pharma’s key brand Kelo-cote around 2020 I believe.
celeritas
29/7/2024
06:50
Good read from Aph for the kelocote and up 20% which I believe we manufacture for them.
deanowls
29/7/2024
06:09
Had hoped for the update this am..
bagpuss67
25/7/2024
16:03
I'm fully loaded!
bagpuss67
25/7/2024
15:31
A tip In itself as he will have the boards ear
basem1
25/7/2024
15:05
Slater Investments increases holding from 18% to 19%.
Hopefully a good omen for next week's trading update.

eagle eye
17/7/2024
18:19
The key executives have a million shares each under option in the 30s….I hope they make loads of money. They are certainly incentivised to find well priced acquisitions and to extend the products they have.
1jat
17/7/2024
09:29
Relative strength has been good, but 12 month rolling prospective PER still only x 8.
In future VLG will report private label brands separately, but this did £2.4m last year and is likely to 'double in size every year for the next two or three years' so could be 10 to 15% of revenue in pretty short order.
Cavendish forecasts net debt falling to £1.9m in 18 months time, but VLG will have been on the acquisition trail by then.
Still early days, but still attractively valued IMHO :-))

eagle eye
17/7/2024
08:30
Share price has been strong this year - up about 50%.
Trading update was issued last year on 31st july with half yarly results announced in late Sept
If there is coninuing good news in these anouncements,the price rise could continue for the rest of the year.

camerongd53
Chat Pages: 1474  1473  1472  1471  1470  1469  1468  1467  1466  1465  1464  1463  Older

Your Recent History

Delayed Upgrade Clock